Literature DB >> 22273503

Association of polymorphisms in C2, CFB and C3 with exudative age-related macular degeneration in a Korean population.

Suk Jin Kim1, Soo Jeong Lee, Na Rae Kim, Hee Seung Chin.   

Abstract

This study was to investigate the association of genetic polymorphisms in complement component 2 (C2), complement factor B (CFB) and complement component 3 (C3) with exudative age-related macular degeneration (AMD) in a Korean population and the gene-gene and gene-environment interactions in the development of AMD. A total of six SNPs that are located in the C2 (rs547154, rs9332739), CFB (rs4151667, rs641153) and C3 (rs1047286, rs2230199) genes were genotyped in 350 samples comprised of 153 cases, 197 controls. The risk allele frequencies for rs547154 in C2 were 6.54% and 8.12% in AMD patients and controls. Those for rs641153 in CFB were 6.54% and 8.63% in AMD patients and controls. The risk allele frequency for rs9332739 in C2 (AMD, 0.65%, control, 2.03%) and rs4151667 in CFB (AMD, 0.65%, control, 1.78%) was very low. The protective allele of four SNPs was not significantly associated with decreased risk for AMD (P = 0.427, P = 0.199, P = 0.312, P = 0.303, respectively). The homozygotes for the protective allele of four SNPs were not significantly associated with decreased risk for AMD (P = 0.324, P = 0.474, P = 0.309, P = 0.411, respectively). The genetic effect of two SNPs in C3 could not be investigated because the variants were not observed. There was no evidence to support an interaction of these SNPs with LOC387715/HTRA1 variants or with environmental exposure like smoking. In conclusion, the genetic effect of C2, CFB and C3 polymorphisms, which are known to be important for AMD in Caucasian, were not significant in the Korean population. The low minor allele frequency of these SNPs in Koreans might have affected the results of this study. Ethnic differences in the roles of C2, CFB and C3 in conferring a risk of AMD should be further investigated. Copyright Â
© 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22273503     DOI: 10.1016/j.exer.2012.01.005

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  8 in total

1.  Genetic risk, ethnic variations and pharmacogenetic biomarkers in age-related macular degeneration and polypoidal choroidal vasculopathy.

Authors:  Jane Z Kuo; Tien Y Wong; Frank S Ong
Journal:  Expert Rev Ophthalmol       Date:  2013-04-01

2.  Association between polymorphisms of complement pathway genes and age-related macular degeneration in a Chinese population.

Authors:  Lin Wu; Qiushan Tao; Wen Chen; Zhi Wang; Yanping Song; Shuangyan Sheng; Pengcheng Li; Jingjing Zhou
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-01-07       Impact factor: 4.799

3.  Complement factor B polymorphism (rs641153) and susceptibility to age-related macular degeneration: evidence from published studies.

Authors:  Xin Wang; Ying Zhang; Mao-Nian Zhang
Journal:  Int J Ophthalmol       Date:  2013-12-18       Impact factor: 1.779

4.  Complement factor H Val62Ile variant and risk of age-related macular degeneration: a meta-analysis.

Authors:  Dongqing Yuan; Qin Yang; Xiaoyi Liu; Donglan Yuan; Songtao Yuan; Ping Xie; Qinghuai Liu
Journal:  Mol Vis       Date:  2013-02-13       Impact factor: 2.367

5.  Associations of 6p21.3 Region with Age-related Macular Degeneration and Polypoidal Choroidal Vasculopathy.

Authors:  Zimeng Ye; Ping Shuai; Yaru Zhai; Fang Li; Lingxi Jiang; Fang Lu; Feng Wen; Lulin Huang; Dingding Zhang; Xiaoqi Liu; Ying Lin; Huaichao Luo; Houbin Zhang; Xianjun Zhu; Zhengzheng Wu; Zhenglin Yang; Bo Gong; Yi Shi
Journal:  Sci Rep       Date:  2016-02-10       Impact factor: 4.379

6.  Copy number variations and gene polymorphisms of complement components in ocular Behcet's disease and Vogt-Koyanagi-Harada syndrome.

Authors:  Dengfeng Xu; Shengping Hou; Jun Zhang; Yanni Jiang; Aize Kijlstra; Peizeng Yang
Journal:  Sci Rep       Date:  2015-08-13       Impact factor: 4.379

7.  The effect of complement factor B gene variation on age-related macular degeneration in Iranian patients.

Authors:  Nasrin Roshanipour; Morteza Bonyadi; Mohammad Hossein Jabbarpour Bonyadi; Masoud Soheilian
Journal:  J Curr Ophthalmol       Date:  2019-08-07

8.  Role of complement factor B rs4151667 (L9H) polymorphisms and its interactional role with CFH Y402H and C3 rs2230199 (R102G) risk variants in age-related macular degeneration: a case control study.

Authors:  Nasrin Roshanipour; Maryam Ghaffari Laleh; Mortaza Bonyadi; Mohammad Hossein Jabbarpoor Bonyadi; Masoud Soheilian; Alireza Javadzadeh; Mehdi Yaseri
Journal:  BMC Ophthalmol       Date:  2020-08-06       Impact factor: 2.209

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.